Failure to maintain donor, processing and general records.
Inspection Record
Biomat USA Inc — FDA 483 Findings
Inspectors Elyshia Q DanaherThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Failure to present educational material to the donor in an appropriate form and in a manner designed to be understood by the donor.
Failure to perform a thorough investigation and makea record of the conclusions and follow-up of an unexplained discrepancy.
Written standard operating procedures including all steps to be followed in the collection and storage of blood and blood components for were not always followed.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
A record as of the US FDA document published on 2026-10-20. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.